Skip to main content

Parenteral Iron and Anaphylactoid Reactions

    Basic Details
    Date Posted
    Friday, July 22, 2016
    Status
    Complete
    Medical Product
    parenteral iron (IV iron)
    Health Outcome(s)
    anaphylactoid reaction
    Description

    This protocol will guide a one-time assessment of the association between parenteral iron products and anaphylactoid/anaphylactic reactions. Protocol-based assessments use study designs and analysis plans customized for the product-outcome pairs being assessed.

    This protocol was posted for public comment from September 4, 2013 through September 18, 2013. The public comment period is now closed. A revised version was approved for implementation by FDA on January 8, 2014. A log of changes is included in the revised protocol (v2.0).

    Additional Details
    FDA Center
    CDER
    Time Period
    2000 - 2012
    Study Type
    Protocol/Surveillance Plan
    Assessment Type
    Safety Analyses
    HOI Study Type
    Validations Supported by Traditional Medical Chart Review
    Population / Cohort
    All non-dialysis individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)
    Workgroup Leader(s)

    Kathleen Walsh MD, MSc; Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Cunlin Wang MD, PhD; Center for Drug Evaluation and Research, FDA, Silver Spring, MD

    Workgroup Members

    Susan Andrade ScD; Joann Wagner MSW; Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA 

    Maryam Asgari MD, MPH; Kaiser Permanente Northern California, Oakland, CA

    Irene Fung MD; Peter Reese MD, MSCE; University of Pennsylvania School of Medicine, Philadelphia, PA

    Monika Houstoun PharmD, MPH; Robert Kane MD; Mark Levenson PhD; Marsha Reichman PhD; Qin Ryan MD, PhD; Diqiong Xie PhD, MS; Center for Drug Evaluation and Research, FDA, Silver Spring, MD

    Lingling Li PhD; Darren Toh ScD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

    Gayathri Sridhar PhD, MBBS, MPH; HealthCore Inc., Wilmington, DE